Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Thyroid Diseases × Fluorescein × Clear all

Phase

Status

Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1 Head & Neck 1

Conditions

Brain Neoplasms 2 Thyroid Diseases 1 Paget Disease, Extramammary 1 Neuroma, Acoustic 1 Glioma 1 Adenolymphoma 1

Interventions

Sorafenib 3 cabozantinib 2 vandetanib 1 temsirolimus 1 pembrolizumab 1 lenvatinib 1 apatinib 1 Vitamin B 12 1 Thyrotropin-Releasing Hormone 1 Pemetrexed 1 Panobinostat 1 Metformin 1 Folic Acid 1 Fluorescein 1 Everolimus 1 Cisplatin 1 Cetuximab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06054178 2025-07-28

Identification of Nerves Using Fluorescein Sodium

Stanford University

Phase 2 Enrolling by invitation

Head & NeckLymphoid

Adenolymphoma, Thyroid Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡